<https://www.drugdeliverybusiness.com/#/schema/person/11584fde442c170de18de3a3d2724217>
<http://schema.org/sameAs>
<https://www.drugdeliverybusiness.com/oncopeptides-completes-enrollment-in-phase-2-multiple-myeloma-study/>